Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal ...

According to the American Cancer Society, basal cell and squamous cell carcinoma are two of the most common types of skin cancer. Here are the biggest differences between the two, via the American ...

A new pilot cohort study linked immune checkpoint inhibitors with a reduction in actinic keratoses in patients undergoing ...

A single-center study suggests the surgery is safe and effective even when tumors are large or located in high-risk areas.

T-VEC enables BCC resectability in 50% of cases, showing promise as a neoadjuvant therapy with mild side effects.

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

While skin cancer is commonly associated with sun exposure, a dermatologist is urging the public to be aware of a ...

Long-term TNFi use in patients with psoriasis was not associated with a higher risk of cancer, including lymphoma, prostate cancer, and breast cancer.

Percentage of biopsies with a diagnosis of cutaneous Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC), or melanoma (including in situ disease) in which the pathologist communicates results ...

Paul Nghiem, MD, PhD, and the Nghiem Lab have championed innovations in MCC treatment, delivering new treatment options, ...